Content
All Posts > Content under Pharma/Biotech
Week In Review: Qiming Venture Closes $1.1 Billion Fund For Healthcare/TMT Investments
Article By:
ChinaBio® Today
Read
Saturday, April 11, 2020 2:34 PM EDT
Qiming closed its seventh China-focused US dollar fund with $1.1 billion for early stage Healthcare and TMT investments. Currently, Qiming manages nine US dollar funds and five RMB funds, with $5.3 billion of assets under management.
Cannabis Central: Sector Had A Very Good Week Up 13.1% From The Previous
Article By:
Lorimer Wilson
Read
Saturday, April 11, 2020 8:26 AM EDT
The Non-penny Pot Stock Index increased by 13.1%% this past week exceeding the 7.7% increase in the total cannabis sector of 319 stocks. 29 of the 36 eligible stocks in the NPSI went up, 2 remained unchanged and the remaining 5 went down in price.
Cannabis Central: Sector Advanced 1.6% Thursday For 6th Straight Day Of Increases
Article By:
Lorimer Wilson
Read
Friday, April 10, 2020 3:50 AM EDT
The Non-penny Pot Stock Index (NPSI) of 34 stocks trading at +US$1/share advanced 1.6% Thursday matching the 1.6% increase in the total cannabis sector (319 stocks) and marginally more than the 1.5% increase in the S&P 500.
Cannabis Central: Sector Increased 3% On Wednesday For 5th Consecutive Day
Article By:
Lorimer Wilson
Read
Thursday, April 9, 2020 7:17 AM EDT
The cannabis sector of 319 stocks increased 3.0% Wednesday, while the Non-penny Pot Stock Index (NPSI) advanced 3.1%. 23 of the 33 stocks in the NPSI went up, 2 remained unchanged and the remaining 8 went down.
Cannabis Central: Sector Increased By 2.3% On Tuesday
Article By:
Lorimer Wilson
Read
Wednesday, April 8, 2020 4:05 AM EDT
The cannabis sector of 319 stocks increased 2.3% Tuesday compared to the Non-penny Pot Stock Index which advanced 1.6%. 18 of the 34 constituent stocks in the NPSI went up, 4 saw no change and 12 went down in price.
Cannabis Central: How Well Do The Two New TSX Cannabis Indexes Track The Industry's Stock Performance?
Article By:
Lorimer Wilson
Read
Tuesday, April 7, 2020 4:28 PM EDT
As a result of the growing interest in the marijuana industry the S&P/TSX recently launched two indices, the S&P/TSX Cannabis Index and the S&P/MX International Cannabis Index to track the performance of specific baskets of cannabis companies.
Cannabis Central's New Non-Penny Pot Stock Index Was UP 6.2% Monday Vs.2.9% For The Total Sector
Article By:
Lorimer Wilson
Read
Tuesday, April 7, 2020 3:38 AM EDT
The total cannabis sector of 319 stocks increased 2.9% on Monday compared to the new Non-penny Pot Stock Index which advanced 6.2%. All but 5 of the 32 constituents stocks in the NPSI went up.
Digital Therapeutics Market To Witness Exponential Growth Amid COVID-19 Outbreak
Article By:
Steve Blade
Read
Monday, April 6, 2020 10:45 AM EDT
Digital therapeutics which empower patients & healthcare providers with intelligent and accessible tools for addressing a wide range of conditions through data-driven interventions has set foothold in North America during the fallout of COVID-19.
The Canadian Cannabis Report - Monday, April 6
Article By:
James Coleman
Read
Monday, April 6, 2020 10:40 AM EDT
It was a very challenging week for Canadian cannabis companies. The relative strength indicator decrease of 14.1% was more than the overall index decline of 12.4%.
Cannabis Central: Only 7 Pot Stocks Now Have Market Caps Above $1B
Article By:
Lorimer Wilson
Read
Monday, April 6, 2020 8:48 AM EDT
At the height of the cannabis stock frenzy back in March/April of 2019, there were 17 companies out of a total of 319 companies listed on the various stock exchanges with valuations over $1 billion but now there are only 7. Here is the list.
Antibe Therapeutics: A Breakthrough In NSAIDs
Article By:
Kieran O'Dea
Read
Sunday, April 5, 2020 11:37 PM EDT
I don't usually recommend an individual stock, let alone a biotech company like Antibe Therapeutics, but here I am...
In this article: ATBPF
Volatile Coronavirus Biotech Stock Plays
Article By:
Rod Raynovich
Read
Saturday, April 4, 2020 9:48 PM EDT
Here are many of the well-followed life science stocks that are in the news with diagnostics, drugs and vaccines that may have an impact on the COVD-19 pandemic.
Cannabis Central: Sector Declined 11.4% Last Week; Only These 5 Advanced
Article By:
Lorimer Wilson
Read
Saturday, April 4, 2020 7:51 PM EDT
Only 32 of the universe of 319 pot stocks closed last week above US$1/share declining -10.8%, on average, versus -6.2% the previous week, and slightly less than the -11.4% decline, on average, for the entire sector.
Week In Review: Signs Of Life After Coronavirus -- China Biopharma Scores $721 Million In Deals
Article By:
ChinaBio® Today
Read
Saturday, April 4, 2020 4:57 PM EDT
Shanghai ZhenGe Biotech, a China CDMO, completed a $51 million Series A financing round led by Shanghai-based healthcare investment firm Lyfe Capita. The company will use the proceeds for additional hires and to expand its Shanghai R&D center
Cannabis Central: Sector Declined 2.5% On Friday With Only These 9 Non-Penny Pot Stocks Advancing
Article By:
Lorimer Wilson
Read
Saturday, April 4, 2020 4:47 PM EDT
Today's article identifies the three non-penny pot stocks that advanced by 5% or more on Friday, the 10 stocks that declined by more than 5% and eight of the remaining stocks that warrant mentioning.